Shingrix OK'd For Immunocompromised Adults

(MedPage Today) -- FDA expanded the approval of Shingrix, an adjuvanted recombinant zoster vaccine, for adults at increased risk of shingles due to immunosuppression, manufacturer GlaxoSmithKline (GSK) announced on Monday.
The expanded indication...